Owlet, Inc. (OWLT) Stock Analysis

Company Overview

Owlet, Inc. (OWLT) is capitalised at $145.52M on the latest close. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 108 employees.

The most recent close on file for OWLT is $4.98, dated September 4, 2026. That is −$0.05 (−0.99%) against the previous close. Over the past 52 weeks the price has ranged from $4.19 to $16.94. The latest close sits 18.85% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $105.71M. Against the prior fiscal year total of $78.06M, that is a change of +35.43%. The same year closed with a net loss of $39.68M. The reported profit margin is −8.44%. That is 6.8 percentage points below the Medical Devices median of −1.69%. Trailing earnings per share are −0.3.

Across the 4 fiscal years on file, revenue moves from $69.20M in 2022 to $105.71M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. On forward earnings the ratio is 51.52. The price-to-sales ratio is 1.27. On price-to-sales that is 57.26% below the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Over the trailing twelve months the price has returned −31.78%. Across 5 years the annualized return works out at −43.98%. The reported beta is 1.9. Annualized volatility over the trailing 5 years is 89.79%.

Growth & Income

No dividend is on file for OWLT.

The strongest complete calendar year on file is 2025 at +263.82%; the weakest is 2022 at −79.06%. Of the 5 complete calendar years on file, 1 finished higher. 2026 is still running; the price is −69.24% year to date.